Two Hands Ultherapy Prime & Aesthetic Lifting Clinic in Gangnam, Seoul · 1:1 Physician Care
Ultherapy & Sofwave Specialized Clinic · Gangnam-daero
en-US
Skin Booster Treatments · Consultation Required
Infuskin
Infuskin is a hybrid, structural-support skin booster that combines cross-linked and non-cross-linked hyaluronic acid (HA) in a double micro-bead formulation.
Schedule a Consultation
Infuskin is a hybrid, structural-support skin booster that combines cross-linked and non-cross-linked hyaluronic acid (HA) in a double micro-bead formulation. Developed to address multiple aspects of skin aging, Infuskin is designed to support natural-looking volume, skin firmness, hydration, and overall skin quality within a single injectable treatment approach.
Hyaluronic acid is a naturally occurring component of the skin's extracellular matrix (ECM), where it plays an important role in retaining moisture and supporting tissue elasticity. As skin ages, changes in hydration, collagen structure, and dermal support can contribute to fine lines, reduced firmness, and a loss of facial fullness.
Infuskin combines two forms of hyaluronic acid with different structural characteristics. Its double micro-bead technology is designed to allow the formulation to break down gradually after injection, potentially providing longer-lasting structural support than rapidly degrading HA formulations.
Rather than focusing exclusively on surface hydration, Infuskin aims to improve the skin's supporting environment while encouraging a naturally refreshed appearance. Its proposed benefits include hydration, subtle volume enhancement, improved elasticity, and support for collagen-related skin remodeling. The degree of improvement depends on individual skin characteristics and treatment technique.
Who needs Infuskin treatment?
Infuskin may be suitable for individuals experiencing changes in facial volume, elasticity, or skin texture who prefer a minimally invasive treatment approach. Candidates for an Infuskin consultation at Maison de M Clinic often include those who:
- Notice early signs of skin laxity and want to improve facial firmness without surgery
- Want natural-looking volume enhancement without a noticeably overfilled appearance
- Are concerned about fine lines, uneven texture, or declining skin smoothness
- Experience dull-looking skin and would like to achieve a more hydrated, radiant appearance
- Want to address skin elasticity and subtle lifting concerns through one treatment approach
- Prefer injectable rejuvenation treatments with limited interruption to daily activities
- Are interested in maintaining skin quality through a personalized treatment plan
Infuskin may be considered for patients with mild to moderate aesthetic concerns, although treatment suitability depends on facial anatomy, medical history, and individual expectations. A consultation with the Maison de M medical team helps determine whether Infuskin is appropriate or whether another treatment would better address the patient's concerns.
Meet the specialists in dermatology at Maison de M Clinic
Min Byung Yee, Chief Director and Board-Certified Family Medicine Specialist, is a graduate of Yonsei University who completed residency training at The Catholic University Central Medical Center. He currently serves as a Visiting Professor at Soonchunhyang University Hospital and holds positions as Clinical Advisor for Ulthera (Merz Korea) and Density, alongside academic lecturing responsibilities for Rejuran and Thermage MTL. His previous experience includes director-level positions at DA Plastic Surgery & Dermatology and ID Hospital Dermatology.
Chang-won Choi, Chief Medical Director, brings extensive leadership experience across aesthetic, anti-aging, and obesity medicine. He is an active member of multiple Korean academic societies and has held director-level positions at Gangnam Thema Dermatology, Myuto Plastic Surgery & Dermatology, Oracle Dermatology in Macau, Tianjin Aesthetic Plastic Hospital in China, Tox & Fill Clinic, and ID Hospital.
Ari Byun, Director and Board-Certified Family Medicine Specialist, graduated from Ewha Womans University College of Medicine, where she completed her internship, residency, and academic appointments at Ewha Womans University Mokdong Hospital and Korea University Anam Hospital. She holds Lifetime Membership in the Korean Association of Clinical Ultrasound and previously served as Director at Cheongdam Lynn Clinic and Maypure Clinic.
Together, these physicians bring clinical backgrounds in family medicine, aesthetic medicine, and dermatologic care. Their consultation-based approach helps patients understand the potential benefits and limitations of Infuskin and develop treatment plans suited to their individual skin concerns.
Treatment areas and expected improvements

Natural facial volume enhancement: Infuskin is designed to provide subtle structural support through its cross-linked hyaluronic acid component. This approach aims to improve the appearance of mild volume loss and support more balanced facial contours without emphasizing dramatic changes in facial shape.
Skin elasticity and lifting: By supporting the skin's underlying tissue environment, Infuskin aims to improve the appearance of firmness and mild laxity. The treatment is positioned as an injectable option for patients seeking a modest tightening or lifting effect, although it cannot reproduce the results of surgical lifting.
Skin hydration and radiance: Hyaluronic acid attracts and retains water, helping support the skin's moisture balance. Infuskin is intended to improve the appearance of dehydrated or dull-looking skin, contributing to a smoother, more hydrated complexion.
Skin texture and fine lines: Infuskin may help soften the appearance of superficial fine lines and uneven texture through hydration and tissue support. The formulation is also promoted as supporting collagen-related remodeling, although the extent of collagen production specifically attributable to Infuskin requires product-specific clinical evidence.
Expected improvements vary depending on the patient's baseline skin condition, injection technique, treatment areas, and individual biological response. A personalized evaluation is necessary to establish realistic expectations regarding volume, firmness, and overall skin quality.
Treatment process and timeline
1. Consultation
Your Infuskin treatment begins with a personalized consultation at Maison de M Clinic. The medical team reviews your aesthetic concerns, treatment goals, medical history, and previous injectable procedures to determine whether Infuskin is a suitable option.
2. Diagnostic assessment
The treating physician examines the areas of concern, including skin elasticity, hydration, facial contours, and visible signs of aging. This assessment helps guide treatment planning and identify areas where subtle volume support or skin-quality improvement may be appropriate.
3. Preparation
Before injection, the treatment area is cleansed and prepared according to the clinic's procedural protocols. The physician determines the appropriate treatment areas, injection technique, and product quantity based on the individual plan. Pain-management measures may be discussed when appropriate.
4. Procedure
Infuskin is administered using an injection technique selected by the treating physician. Its hyaluronic acid formulation is designed to provide tissue support and hydration while distributing the product according to the intended treatment outcome. The injection depth and placement depend on the clinical assessment and applicable product instructions.
5. Immediate aftercare
Following treatment, patients may experience temporary redness, swelling, tenderness, or small injection-site marks. The medical team provides individualized aftercare instructions, including precautions regarding pressure on treated areas, skincare products, and certain activities during the initial recovery period.
6. Follow-up timeline
Some changes in hydration or volume may be noticeable relatively early, while the final appearance should be assessed after initial swelling has settled. Follow-up appointments and any additional treatment sessions are scheduled according to individual response, treatment goals, and the physician's recommendations.
Results, safety, and longevity

Infuskin is designed to address several interconnected aspects of skin appearance through its hybrid hyaluronic acid formulation. Cross-linked HA provides structural support and is generally more resistant to rapid breakdown, while non-cross-linked HA contributes to hydration-related properties. Together, these components are intended to support natural-looking volume, skin smoothness, and elasticity.
The manufacturer's published information identifies Infuskin as a hyaluronic acid-based medical device authorized by South Korea's Ministry of Food and Drug Safety (MFDS) for temporary improvement of adult facial wrinkles through subcutaneous injection. Its published clinical evaluation includes assessment of nasolabial fold improvement. Broader benefits promoted for skin regeneration and lifting should be understood as treatment objectives rather than guaranteed clinical outcomes.
The duration of visible results varies according to injection technique, treatment area, product behavior, individual metabolism, and lifestyle factors. Although the double micro-bead formulation is promoted as providing gradual breakdown, a specific duration of cosmetic improvement should not be promised without applicable clinical evidence.
As with other HA-based injectable treatments, temporary swelling, redness, bruising, tenderness, or localized irregularities may occur. Less common but potentially serious complications include infection, inflammatory nodules, and unintended injection into a blood vessel, which may cause tissue injury or, in rare circumstances, visual complications.
Patients should inform their physician about relevant allergies, current medications, previous injectable treatments, pregnancy or breastfeeding, and any active skin infections or medical conditions. An appropriately trained medical professional should assess contraindications and explain potential risks before treatment.
Why choose Maison de M Clinic for Infuskin treatment?

Maison de M Clinic offers Infuskin within a personalized aesthetic treatment framework supported by physicians with backgrounds in family medicine, aesthetic medicine, and dermatologic practice. The clinic focuses on understanding each patient's skin concerns before determining the most appropriate injectable treatment approach.
Rather than treating skin hydration, volume, and elasticity as entirely separate concerns, Infuskin offers an approach intended to address these aspects together. Its hybrid HA formulation can be considered when the treatment goal is subtle facial rejuvenation while maintaining natural-looking contours.
The medical team's professional backgrounds include university hospital affiliations, academic activities, clinical advisory appointments, and previous leadership positions at aesthetic medical institutions. These experiences contribute to individualized consultations and treatment planning.
Key differentiators of Infuskin treatment at Maison de M Clinic include:
- A hybrid hyaluronic acid formulation combining cross-linked and non-cross-linked HA
- Double micro-bead technology designed to support gradual product breakdown
- A treatment approach focused on natural-looking volume, hydration, and skin elasticity
- Individualized injection planning based on facial anatomy and skin concerns
- A multidisciplinary physician team experienced in aesthetic medical treatments
Real patient experiences
The following examples illustrate common consultation concerns. They are not verified patient testimonials or documented Infuskin treatment outcomes.
Case reflection: Addressing early facial volume loss
A patient in her late thirties notices that her facial contours appear less full and her skin has gradually lost some firmness. She prefers a treatment that focuses on subtle improvement rather than dramatic volume enhancement.
During consultation, the physician may evaluate whether Infuskin's hyaluronic acid-based structural support is appropriate for her concerns, while discussing realistic outcomes and the limitations of injectable lifting.
Case reflection: Improving skin hydration and texture
Another patient is concerned about dull-looking skin, uneven texture, and increasingly noticeable fine lines. Although her skincare routine provides temporary hydration, she is interested in exploring an injectable approach to skin-quality improvement.
Following an assessment of skin condition and medical history, the physician may consider Infuskin as one possible treatment option, with goals focused on improving hydration-related appearance, smoothness, and subtle facial refinement.
Ready to restore your skin's volume and elasticity with Infuskin?
If you have noticed reduced facial firmness, mild volume loss, fine lines, or declining skin radiance, a personalized Infuskin consultation at Maison de M Clinic can help you explore whether this hybrid hyaluronic acid treatment is appropriate for your needs.
By combining hydration-focused properties with structural tissue support, Infuskin offers an injectable approach intended to improve multiple aspects of skin appearance. Every treatment plan begins with an individualized medical assessment, helping patients understand potential benefits, safety considerations, and realistic expectations.
Contact Maison de M Clinic today to schedule your Infuskin consultation and discuss a personalized approach to natural-looking facial rejuvenation with the medical team.
More Treatments
Explore additional Ultherapy Prime, Sofwave, Thermage FLX, skin booster, filler, and stem-cell treatments at Maison de M Clinic.
Two hands New Ulthera Prime
Two Hands New Ulthera Prime is a non-surgical ultrasound lifting treatment designed to improve skin elasticity, facial firmness, and symmetry.
Learn More
PTING Laser
PTING Laser uses ultra-high frequency microwave energy to deliver controlled thermal stimulation to deeper tissue layers.
Learn More
Sofwave
Sofwave is a lifting procedure that delivers concentrated ultrasound energy to the dermis layer at a depth of 1.5 mm using seven specialized transducers and SUPERB™ technology.
Learn More